Growth hormone. GLP-1 response. BPC-157’s regenerative signaling. The molecules that built you in your twenties are now being rationed. Oria is the encyclopedia that maps what can be replaced — and how.
Built for the version of you that’s still becoming.
Four signals. One protocol.
Body Protective Compound · 15 amino acids
GLP-1 receptor agonist · 31 amino acids
Synthetic tuftsin analogue · 7 amino acids
Thymosin Beta-4 fragment · 43 amino acids
Triple-acting incretin · 39 amino acids
Growth hormone secretagogue · 5 amino acids
Latest updates
Oct 29, 2026
A prospectively registered systematic review just graded every human study of BPC-157. It found three trials, thirty people, and a very low certainty rating. Here is what that means if you are weighing the peptide.
Oct 27, 2026
No research peptide is FDA-approved for human use, and none of the popular ones has a federal pathway a pharmacy can use today. The policy that would open a temporary door has been sitting unpublished at the White House since 14 October 2026.
Oct 27, 2026
Large real-world data say GLP-1 drugs reduce fragility fractures. The randomized bone-density trials say they pull density out of skeleton. Here is why both are true, and what it means for your bones.
